Switch to:
More From Other Websites
Rahul Garg Says Trump's Tweets About Drug Prices Have Made Gilead A Buy Mar 28 2017
Gilead’s Hep C Bestseller Faces Patent Dispute (GILD) Mar 27 2017
Gilead hepatitis C drug patent faces European challenge Mar 27 2017
Alphabet, Allergan, Ford: Doug Kass' Views Mar 27 2017
Biotechs Back in the Doghouse After Failed Rally Mar 23 2017
Mylan Receives Tentative Approval from FDA for HIV Therapy Mar 21 2017
British Columbia lists EPCLUSA™ on public drug plan to treat all six genotypes of chronic... Mar 21 2017
Gilead Sciences: Wait, Its Pipeline Isn't Completely Barren? Mar 20 2017
EPCLUSA™, to treat all six genotypes of chronic hepatitis C infection, added to the Liste des... Mar 20 2017
Why Biotech Stock Gilead (GILD) Could Be a Value Trap Mar 20 2017
Jefferies Has 4 Red-Hot Biotech and Pharmaceutical Stocks to Buy Now Mar 20 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK